193 related articles for article (PubMed ID: 33364237)
21. UMMS-4 enhanced sensitivity of chemotherapeutic agents to ABCB1-overexpressing cells via inhibiting function of ABCB1 transporter.
Qiao D; Tang S; Aslam S; Ahmad M; To KK; Wang F; Huang Z; Cai J; Fu L
Am J Cancer Res; 2014; 4(2):148-60. PubMed ID: 24660104
[TBL] [Abstract][Full Text] [Related]
22. Biological evaluation of non-basic chalcone CYB-2 as a dual ABCG2/ABCB1 inhibitor.
Cai CY; Zhang W; Wang JQ; Lei ZN; Zhang YK; Wang YJ; Gupta P; Tan CP; Wang B; Chen ZS
Biochem Pharmacol; 2020 May; 175():113848. PubMed ID: 32044354
[TBL] [Abstract][Full Text] [Related]
23. Alpha-Mangostin Reverses Multidrug Resistance by Attenuating the Function of the Multidrug Resistance-Linked ABCG2 Transporter.
Wu CP; Hsiao SH; Murakami M; Lu YJ; Li YQ; Huang YH; Hung TH; Ambudkar SV; Wu YS
Mol Pharm; 2017 Aug; 14(8):2805-2814. PubMed ID: 28641010
[TBL] [Abstract][Full Text] [Related]
24. Tepotinib reverses ABCB1-mediated multidrug resistance in cancer cells.
Wu ZX; Teng QX; Cai CY; Wang JQ; Lei ZN; Yang Y; Fan YF; Zhang JY; Li J; Chen ZS
Biochem Pharmacol; 2019 Aug; 166():120-127. PubMed ID: 31078601
[TBL] [Abstract][Full Text] [Related]
25. Quizartinib (AC220) reverses ABCG2-mediated multidrug resistance:
Li J; Kumar P; Anreddy N; Zhang YK; Wang YJ; Chen Y; Talele TT; Gupta K; Trombetta LD; Chen ZS
Oncotarget; 2017 Nov; 8(55):93785-93799. PubMed ID: 29212189
[TBL] [Abstract][Full Text] [Related]
26. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.
Shi Z; Peng XX; Kim IW; Shukla S; Si QS; Robey RW; Bates SE; Shen T; Ashby CR; Fu LW; Ambudkar SV; Chen ZS
Cancer Res; 2007 Nov; 67(22):11012-20. PubMed ID: 18006847
[TBL] [Abstract][Full Text] [Related]
27. MET inhibitor tepotinib antagonizes multidrug resistance mediated by ABCG2 transporter:
Wu ZX; Teng QX; Yang Y; Acharekar N; Wang JQ; He M; Yoganathan S; Lin J; Wang J; Chen ZS
Acta Pharm Sin B; 2022 May; 12(5):2609-2618. PubMed ID: 35646541
[TBL] [Abstract][Full Text] [Related]
28. Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo.
Hu J; Zhang X; Wang F; Wang X; Yang K; Xu M; To KK; Li Q; Fu L
Oncotarget; 2015 Dec; 6(42):44643-59. PubMed ID: 26556876
[TBL] [Abstract][Full Text] [Related]
29. Midostaurin Reverses ABCB1-Mediated Multidrug Resistance, an
Ji N; Yang Y; Cai CY; Wang JQ; Lei ZN; Wu ZX; Cui Q; Yang DH; Chen ZS; Kong D
Front Oncol; 2019; 9():514. PubMed ID: 31275850
[TBL] [Abstract][Full Text] [Related]
30. Dual TTK/CLK2 inhibitor, CC-671, selectively antagonizes ABCG2-mediated multidrug resistance in lung cancer cells.
Wu ZX; Yang Y; Wang G; Wang JQ; Teng QX; Sun L; Lei ZN; Lin L; Chen ZS; Zou C
Cancer Sci; 2020 Aug; 111(8):2872-2882. PubMed ID: 32478948
[TBL] [Abstract][Full Text] [Related]
31. Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2.
Dai CL; Liang YJ; Wang YS; Tiwari AK; Yan YY; Wang F; Chen ZS; Tong XZ; Fu LW
Cancer Lett; 2009 Jun; 279(1):74-83. PubMed ID: 19232821
[TBL] [Abstract][Full Text] [Related]
32. NVP-CGM097, an HDM2 Inhibitor, Antagonizes ATP-Binding Cassette Subfamily B Member 1-Mediated Drug Resistance.
Zhang M; Chen XY; Dong XD; Wang JQ; Feng W; Teng QX; Cui Q; Li J; Li XQ; Chen ZS
Front Oncol; 2020; 10():1219. PubMed ID: 32793491
[TBL] [Abstract][Full Text] [Related]
33. Sitravatinib Sensitizes ABCB1- and ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Drugs.
Wu CP; Hsiao SH; Huang YH; Hung LC; Yu YJ; Chang YT; Hung TH; Wu YS
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31941029
[TBL] [Abstract][Full Text] [Related]
34. SIS3, a specific inhibitor of Smad3 reverses ABCB1- and ABCG2-mediated multidrug resistance in cancer cell lines.
Wu CP; Murakami M; Hsiao SH; Liu TC; Yeh N; Li YQ; Hung TH; Wu YS; Ambudkar SV
Cancer Lett; 2018 Oct; 433():259-272. PubMed ID: 30026175
[TBL] [Abstract][Full Text] [Related]
35. Interactions of cyclin-dependent kinase inhibitors AT-7519, flavopiridol and SNS-032 with ABCB1, ABCG2 and ABCC1 transporters and their potential to overcome multidrug resistance in vitro.
Cihalova D; Staud F; Ceckova M
Cancer Chemother Pharmacol; 2015 Jul; 76(1):105-16. PubMed ID: 25986678
[TBL] [Abstract][Full Text] [Related]
36. PCI29732, a Bruton's Tyrosine Kinase Inhibitor, Enhanced the Efficacy of Conventional Chemotherapeutic Agents in ABCG2-Overexpressing Cancer Cells.
Ge C; Wang F; Cui C; Su X; To KKW; Wang X; Zhang H; Song X; Fu L
Cell Physiol Biochem; 2018; 48(6):2302-2317. PubMed ID: 30114704
[TBL] [Abstract][Full Text] [Related]
37. Reversal of ABCB1-related multidrug resistance by ERK5-IN-1.
Wang F; Li D; Zheng Z; Kin Wah To K; Chen Z; Zhong M; Su X; Chen L; Fu L
J Exp Clin Cancer Res; 2020 Mar; 39(1):50. PubMed ID: 32164732
[TBL] [Abstract][Full Text] [Related]
38. Enhancing chemosensitivity in ABCB1- and ABCG2-overexpressing cells and cancer stem-like cells by an Aurora kinase inhibitor CCT129202.
Cheng C; Liu ZG; Zhang H; Xie JD; Chen XG; Zhao XQ; Wang F; Liang YJ; Chen LK; Singh S; Chen JJ; Talele TT; Chen ZS; Zhong FT; Fu LW
Mol Pharm; 2012 Jul; 9(7):1971-82. PubMed ID: 22632055
[TBL] [Abstract][Full Text] [Related]
39. Ceritinib Enhances the Efficacy of Substrate Chemotherapeutic Agent in Human ABCB1-Overexpressing Leukemia Cells In Vitro, In Vivo and Ex-Vivo.
Yang L; Li M; Wang F; Zhen C; Luo M; Fang X; Zhang H; Zhang J; Li Q; Fu L
Cell Physiol Biochem; 2018; 46(6):2487-2499. PubMed ID: 29742496
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of ABCB1 Transporter Confers Resistance to mTOR Inhibitor WYE-354 in Cancer Cells.
Wang J; Yang DH; Yang Y; Wang JQ; Cai CY; Lei ZN; Teng QX; Wu ZX; Zhao L; Chen ZS
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32092870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
